Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Progression Free Survival

Mixed Results for New Tx in Adrenal Cancer

Patients with advanced adrenocortical carcinoma lived no longer when standard therapy was combined with three-agent chemotherapy, but had a significantly higher response rate and progression-free survival (PFS), results of a large multicenter study showed.

Overall survival improved by almost 3 months with etoposide-doxorubicin-cisplatin (EDP) chemotherapy plus mitotane when compared with mitotane plus streptozocin, but… Mixed Results for New Tx in Adrenal Cancer   



phosphate stones2 - urinary tract infections8 - renal tissue1 - carboplatin1 - stress incontinence5 - berger's disease1 - nephrology workforce1 - advanced renal disease1 - sacrum1 - dyspareunia3 - monosomy1 - voiding dysfunction5 - metastatic tumours1 - uterine cancer2 - polycystic disease1 - stinky urine1 - recurrent infections2 - early-stage prostate cancer2 - early kidney disease1 - voiding symptoms1 - prostate symptoms1 - conners parent rating scale-revised1 - urologist1 - distal tubule1 - prostate biopsy4 - inf21 - urinary crystals2 - alpha blockers1 - thiazides1 - severe lower urinary tract symptoms1 -